Sigachi Industries aims to increase Revenue Potential by INR 250

Hyderabad (Telangana) [India], January 23: Sigachi Industries Ltd. (NSE: SIGACHI; BSE: 543389), a leading Indian...

Anlon Healthcare Delivers Over 102% Profit Growth in H1 FY26

Rajkot (Gujarat) [India], November 13: Anlon Healthcare Limited, one of India's leading manufacturers of high-purity...

Sigachi Industries Sets the Gold Standard in MCC

Hyderabad (Telangana) [India], June 13: Sigachi Industries Ltd., India's largest producer of Microcrystalline...

Remlife Global Partners With JiyaYu Lifesciences

New Delhi [India], May 9: Remlife Global PTE LTD., a Singapore-based subsidiary of BSE-listed Remedium Lifecare Ltd....

Zydus Takeda marks 25 years of manufacturing operations in India

Mumbai, Vashi (Maharashtra) [India], January 31: Zydus Takeda Healthcare Private Limited (ZTHPL), a joint venture...

Atul Bioscience Receives EIR from US FDA for Ambernath Facility

Mumbai (Maharashtra) [India], August 12: Atul Bioscience Ltd (ABL), a 100 per cent subsidiary company of Atul...

India extends humanitarian aid to Cuba: MEA

India has extended humanitarian assistance to Cuba, which includes a consignment of approx 90 tonnes of nine Made...

Medec Medicare Limited Bags Prestigious India's Best Start up

Mumbai (Maharashtra) [India], May 23: Medec Medicare Limited, India's fastest growing global pharmaceutical company...

Morepen Laboratories Limited' Q3 FY24 EBITDA Surges by 151%

Mumbai (Maharashtra) [India], February 3: Morepen Laboratories Limited (NSE: MOREPENLAB, BSE: 500288), is engaged in...

Infinium Pharmachem Limited announces its IPO for March 31, 2023

New Delhi [India], March 27 (ANI/PNN): Infinium Pharmachem Limited, engaged in the manufacturing and supplying of...

Pharma MNCs finding it difficult to survive in Pakistan

Islamabad [Pakistan], July 25 (ANI): Several foreign pharmaceutical multinational corporations (MNCs) are planning...

Rising input costs to hurt profitability of Indian pharma: Report

New Delhi [India], July 19 (ANI): Faced with rising prices of active pharmaceutical ingredients (APIs), and other...